Albion Financial Group UT Has $15.69 Million Position in iShares Biotechnology ETF $IBB

Albion Financial Group UT increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 123,993 shares of the financial services provider’s stock after buying an additional 172 shares during the quarter. iShares Biotechnology ETF comprises approximately 1.0% of Albion Financial Group UT’s investment portfolio, making the stock its 29th biggest position. Albion Financial Group UT owned about 0.30% of iShares Biotechnology ETF worth $15,686,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the company. Citigroup Inc. raised its position in iShares Biotechnology ETF by 88.5% during the 1st quarter. Citigroup Inc. now owns 3,208,144 shares of the financial services provider’s stock worth $410,322,000 after purchasing an additional 1,505,976 shares during the last quarter. Commonwealth Equity Services LLC boosted its stake in shares of iShares Biotechnology ETF by 12.0% in the 1st quarter. Commonwealth Equity Services LLC now owns 194,516 shares of the financial services provider’s stock worth $24,879,000 after buying an additional 20,915 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in iShares Biotechnology ETF by 763.3% in the first quarter. Jones Financial Companies Lllp now owns 151,265 shares of the financial services provider’s stock valued at $19,347,000 after purchasing an additional 133,744 shares during the last quarter. MAI Capital Management lifted its stake in iShares Biotechnology ETF by 4.2% in the first quarter. MAI Capital Management now owns 98,158 shares of the financial services provider’s stock valued at $12,554,000 after purchasing an additional 3,923 shares during the last quarter. Finally, Madrona Financial Services LLC raised its holdings in iShares Biotechnology ETF by 153.0% during the 1st quarter. Madrona Financial Services LLC now owns 81,150 shares of the financial services provider’s stock valued at $10,379,000 after acquiring an additional 49,075 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.4%

iShares Biotechnology ETF stock opened at $140.96 on Monday. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $150.04. The firm’s fifty day moving average price is $137.83 and its 200-day moving average price is $129.50.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were given a $0.0828 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 annualized dividend and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.